Molecular Data | SC 13G: Statement of acquisition of beneficial ownership by individuals-TB Alternative Assets Ltd(5.23%)
Molecular Data | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.
Molecular Data | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TB Alternative Assets Ltd(4.84%)
Molecular Data | SC 13G: Statement of acquisition of beneficial ownership by individuals-TB Alternative Assets Ltd(4.84%)
Molecular Data | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Molecular Data | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Streeterville Capital LLC(9.99*%),Streeterville Management LLC(9.99*%), etc.
Molecular Data | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular Data | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular Data | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular Data | F-6EF: Auto effective registration statement for American Depositary Receipts representing securities of certain foreign private issuers
Molecular Data | NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
Molecular Data | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-MAX SMART LIMITED (“MAX SMART”)(0.0%),SHANGHAI ZHERONG INVESTMENT CENTRE LIMITED PARTNERSHIP (“SHANGHAI ZHERONG INVEST”)(0.0%), etc.
Molecular Data | SC 13G: Statement of acquisition of beneficial ownership by individuals-TB Alternative Assets Ltd(4.64%)
Molecular Data | SC 13G: Statement of acquisition of beneficial ownership by individuals-TB Alternative Assets Ltd(6.18%)
Molecular Data | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
Molecular Data | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular Data | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular Data | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular Data | 6-K: Report of foreign issuer [Rules 13a-16 and 15d-16]
Molecular Data | 424B5: Prospectus
No Data